Alpha Tau Medical Announces First Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ -- Alpha Tau Medical Ltd. (NASDAQ: DRTS) (NASDAQ: DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer...

Related Keywords

Jerusalem ,Israel General ,Israel ,Japan ,United States ,Canada ,Texas ,Israeli ,Canadian ,Japanese ,Itzhak Kelson ,Alpha Da ,Yona Keisari ,University Of Texas Md Anderson Cancer Center ,Company Board Of Directors ,Healthcare Capital Corp ,Nasdaq ,Alpha Tau Medical Ltd ,Exchange Commission ,Company Japanese ,Prnewswire Alpha Tau Medical Ltd ,Tel Aviv University ,Memorial Sloan Kettering Cancer Center ,Tau Medical ,Alpha Tau ,Memorial Sloan Kettering Cancer ,Cancer Center ,Private Investment ,Public Equity ,Nasdaq Capital Market ,Targets Include ,Diffusing Alpha Emitters Radiation Therapy ,Alpha Tau Medical ,Tel Aviv ,Private Securities Litigation Reform Act ,Annual Report ,United States Securities ,Relations Contact ,